Bard® InLay Optima® Multilength Ureteral Stent 788700Recalls & reported problems
C. R. Bard, Inc. · INLAY OPTIMA MULTILENGTH URETERAL STENT W/O GUIDEWIRE · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00801741015793), received between Apr 30, 2021 and Aug 17, 2022 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Calcified” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Calcified1
- Material Fragmentation1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 17, 2022Material Fragmentation; Material Fragmentation
IT WAS REPORTED THAT THE DOUBLE J URETERAL STENT CAME STRAIGHT OUT OF THE BOX AND ALSO STATED THAT THE BREAKAGE COULD OCCUR LATER. PER FOLLOW-UP INFORMATION RECEIVED FROM IBC ON 12AUG2022, STATED THAT THE DOUBLE J STENT WAS FOUND LIKE THIS IN THE PACKAGE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15243404 ↗MalfunctionApr 30, 2021Calcified; Calcified
IT WAS REPORTED THAT WHEN THE CUSTOMER WAS ASKED TO EXPLAIN THE CLINICAL BENEFITS TO THE HEALTH CARE PROFESSIONAL THEY STATED "PROBLEM IF IT REMAINS IN PLACE OVER A LONG TERM (CRYSTAL FORMATION AND OBSTRUCTION)."
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11754214 ↗
Other STENT, URETERAL devices
- Bard® InLay Optima® Ureteral Stent 788426C. R. Bard, Inc. · STENT, URETERAL1 recall100 reports
- Bard® InLay Optima® Ureteral Stent 788626C. R. Bard, Inc. · STENT, URETERAL122 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777626C. R. Bard, Inc. · STENT, URETERAL118 reports
- Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777426C. R. Bard, Inc. · STENT, URETERAL108 reports
- Bard® InLay® Ureteral Stent 778626C. R. Bard, Inc. · STENT, URETERAL100 reports
- Percuflex™ Plus M0061752530Boston Scientific Corporation · STENT, URETERAL1 death99 reports
- Contour VL™ M0061801560Boston Scientific Corporation · STENT, URETERAL1 recall45 reports
- Polaris™ Ultra M0061921330Boston Scientific Corporation · STENT, URETERAL71 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page